# Safety of FMT Using Oral Encapsulated PRIM-DJ2727 in HIV

> **NCT03329560** · PHASE1 · COMPLETED · sponsor: **The University of Texas Health Science Center, Houston** · enrollment: 6 (actual)

## Conditions studied

- HIV-1-infection

## Interventions

- **BIOLOGICAL:** Oral fecal microbiota transplantation

## Key facts

- **NCT ID:** NCT03329560
- **Lead sponsor:** The University of Texas Health Science Center, Houston
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-04-12
- **Primary completion:** 2019-10-08
- **Final completion:** 2019-10-08
- **Target enrollment:** 6 (ACTUAL)
- **Last updated:** 2020-05-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03329560

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03329560, "Safety of FMT Using Oral Encapsulated PRIM-DJ2727 in HIV". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03329560. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*